###begin article-title 0
Central Exercise Action Increases the AMPK and mTOR Response to Leptin
###end article-title 0
###begin p 1
Conceived and designed the experiments: ERR MFAF MBF MJS JBC. Performed the experiments: ERR MFAF MBF MU SR RM DEC. Analyzed the data: ERR MFAF LAV MJS JBC. Contributed reagents/materials/analysis tools: SR RM DEC LAV KGF MJS. Wrote the paper: ERR MFAF JBC.
###end p 1
###begin p 2
###xml 421 425 <span type="species:ncbi:10116">rats</span>
###xml 709 713 <span type="species:ncbi:10116">rats</span>
###xml 1075 1079 <span type="species:ncbi:10116">rats</span>
###xml 1157 1161 <span type="species:ncbi:10116">rats</span>
AMP-activated protein kinase (AMPK) and mammalian Target of Rapamycin (mTOR) are key regulators of cellular energy balance and of the effects of leptin on food intake. Acute exercise is associated with increased sensitivity to the effects of leptin on food intake in an IL-6-dependent manner. To determine whether exercise ameliorates the AMPK and mTOR response to leptin in the hypothalamus in an IL-6-dependent manner, rats performed two 3-h exercise bouts, separated by one 45-min rest period. Intracerebroventricular IL-6 infusion reduced food intake and pretreatment with AMPK activators and mTOR inhibitor prevented IL-6-induced anorexia. Activators of AMPK and fasting increased food intake in control rats to a greater extent than that observed in exercised ones, whereas inhibitor of AMPK had the opposite effect. Furthermore, the reduction of AMPK and ACC phosphorylation and increase in phosphorylation of proteins involved in mTOR signal transduction, observed in the hypothalamus after leptin infusion, were more pronounced in both lean and diet-induced obesity rats after acute exercise. Treatment with leptin reduced food intake in exercised rats that were pretreated with vehicle, although no increase in responsiveness to leptin-induced anorexia after pretreatment with anti-IL6 antibody, AICAR or Rapamycin was detected. Thus, the effects of leptin on the AMPK/mTOR pathway, potentiated by acute exercise, may contribute to appetite suppressive actions in the hypothalamus.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Richard1">[1]</xref>
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Rivest1">[3]</xref>
###xml 311 314 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wing1">[4]</xref>
###xml 528 531 528 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Shapiro1">[6]</xref>
###xml 697 700 697 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 702 705 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Heymsfield1">[7]</xref>
###xml 707 710 707 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-VanHeek1">[8]</xref>
###xml 666 672 <span type="species:ncbi:9606">humans</span>
Prolonged exercise of medium to high intensity is known to profoundly affect energy balance [1]-[3]. Studies of individuals who have maintained significant weight loss for >1 year have demonstrated that dieters who achieve long-term success are often those who engage in regular and extensive exercise programs [4]. Although the energy expenditure aspects of such exercise may contribute to the effects of weight maintenance, it has been suggested that exercise may also contribute to the energy balance by altering food intake [5], [6]. Rodents submitted to exercise have increased sensitivity to leptin, conversely animals with diet-induced obesity and most obese humans are resistant to leptin [5], [7], [8]. Thus, the mechanism for leptin increased responsiveness in exercise is of great interest and understanding this mechanism could lead to new approaches to prevent or treat obesity.
###end p 4
###begin p 5
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Schwartz1">[9]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Gao1">[10]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Minokoshi1">[12]</xref>
###xml 872 876 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Cota1">[13]</xref>
###xml 1055 1059 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Brunn1">[14]</xref>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Ropelle1">[15]</xref>
###xml 1195 1199 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Shamji1">[16]</xref>
###xml 1279 1283 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Dennis1">[17]</xref>
###xml 1358 1362 1358 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Ropelle1">[15]</xref>
###xml 1364 1368 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Inoki1">[18]</xref>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Gleason1">[20]</xref>
The hypothalamus plays a central role in integrating hormonal (leptin and insulin) and nutritional signals from the periphery and modulating food intake, energy expenditure, and peripheral metabolism [9]. Multiple factors control food intake, including hormones, fuels and behaviour. AMPK is the downstream component of a kinase cascade that acts as a sensor of cellular energy charge, being activated by rising AMP coupled with falling ATP. Once activated, AMPK phosphorylates acetyl-CoA carboxylase (ACC) and switches on energy-producing pathways at the expense of energy-depleting processes [10]-[12]. Another target molecule for the control of food intake and energy homeostasis is represented by the phosphoprotein mammalian target of rapamycin, mTOR, in which the PI(3)K/Akt pathway has been suggested to affect the mTOR phosphorylation state and catalytic activity [13]. Activated signaling through mTOR phosphorylates the serine/threonine kinase p70S6K and the translational repressor eukaryotic initiation factor (eIF) 4E binding protein (4EBP1) [14], [15]. mTOR signaling is inhibited under conditions of low nutrients, such as glucose and amino acids and low intracellular ATP levels [16]. While mTOR was presumed to serve as the direct cellular sensor for ATP levels [17], mounting evidence has implicated AMPK in the regulation of mTOR activity [15], [18]-[20].
###end p 5
###begin p 6
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Pedersen1">[21]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Penkowa1">[22]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Steensberg1">[23]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Keller1">[24]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Lyngso1">[25]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Ruderman1">[26]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Kelly1">[27]</xref>
###xml 603 606 603 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wallenius1">[28]</xref>
###xml 863 867 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Lutticken1">[29]</xref>
###xml 868 872 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Narazaki1">[31]</xref>
###xml 938 942 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Lutticken1">[29]</xref>
###xml 944 948 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Murakami1">[30]</xref>
###xml 950 954 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Sadowski1">[32]</xref>
###xml 1048 1052 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Chen1">[33]</xref>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
The level of circulating interleukin-6 (IL-6) increases dramatically in response to exercise [21], with IL-6 being produced by working muscle [22], [23] and adipose tissue [24], [25] and its concentration correlates temporally with increases in AMPK in multiple tissues [26]. In addition, AMPK activity is diminished in IL-6 deficient mice at rest and the absolute increases in AMPK activity in these tissues caused by exercise is diminished compared with control mice [27]. It also appears that centrally-acting IL-6 plays a role in the regulation of appetite, energy expenditure, and body composition [5], [28]. The signaling mechanism of IL-6 in the hypothalamus is, however, not fully understood. In cells, binding IL-6 to the alpha subunit of its receptor triggers the recruitment of gp130, subsequently leading to the activation of the gp130-associated JAK [29]-[31]. JAK links cytokine receptor to the STAT3 and MAP kinase pathway [29], [30], [32]. In addition to JAK/STAT and MAP kinase pathways, IL-6 also activates the PI(3)K/Akt pathway [33].
###end p 6
###begin p 7
###xml 174 178 <span type="species:ncbi:10116">rats</span>
###xml 412 416 <span type="species:ncbi:10116">rats</span>
In this study, we sought to determine whether the improved response of the AMPK and mTOR pathways to leptin could contribute to the increased molecular response of leptin in rats submitted to exercise in an IL-6-dependent manner. We therefore, examined hypothalamic modulation of AMPK/ACC and mTOR signaling pathways, induced by IL-6, as well as the role of IL-6 in those signaling pathways induced by leptin in rats after acute exercise.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
IL-6 decreases hypothalamic AMPK and increases mTOR signaling
###end title 9
###begin p 10
###xml 217 226 217 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1a</xref>
###xml 330 339 330 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1b</xref>
###xml 526 535 514 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1c</xref>
###xml 601 610 577 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1d</xref>
###xml 745 761 721 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figures 1e and f</xref>
###xml 820 836 796 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figures 1g and h</xref>
###xml 930 956 902 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figures 1e&#8211;h, lower panels</xref>
###xml 114 118 <span type="species:ncbi:10116">rats</span>
###xml 428 432 <span type="species:ncbi:10116">rats</span>
###xml 588 599 <span type="species:ncbi:10116">Wistar rats</span>
To determine whether IL-6 modulates hypothalamic AMPK/ACC signaling, we injected IL-6 into the third ventricle of rats and evaluated food intake and AMPK signaling. IL-6 caused a significant reduction in food intake (Figure 1a). We next investigated whether the microinfusion of IL-6 modulates the hypothalamic ATP concentration. Figure 1b shows that IL-6 (200 ng) changed ATP, ADP and AMP concentrations in the hypothalamus of rats, whereas, sixty minutes after IL-6 injection, the ATP content increased by approximately88% (Figure 1c) and decreased AMP:ATP ratio by approximately54% in Wistar rats (Figure 1d). Consistent with the modulation of the AMP:ATP ratio, we observed reduced hypothalamic AMPK and ACC phosphorylation induced by IL-6 (Figures 1e and f); whilst IL-6 increases p70S6K and 4EBP1 phosphorylation (Figures 1g and h). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 1e-h, lower panels).
###end p 10
###begin title 11
Effects of IL-6 on food intake, hypothalamic AMPK/mTOR activity and ATP content.
###end title 11
###begin p 12
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 481 487 481 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 550 555 550 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 621 627 621 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 701 706 701 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 1119 1120 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1127 1130 1125 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1148 1149 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1156 1159 1154 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1177 1178 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1185 1188 1183 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 456 467 <span type="species:ncbi:10116">Wistar rats</span>
###xml 1057 1061 <span type="species:ncbi:10116">rats</span>
(a) Effect of i.c.v. administration of IL-6 on food intake; pretreatment with AICAR blocks IL-6-induced anorexia (n = 12-15 animals per group). (b, c, d) Typical chromatographic run (b) depicting the ATP, ADP, and AMP fractions in control (black line) and in i.c.v. IL-6 treated animals (red line), as mean ATP content and as AMP:ATP ratio (c, d). (e, f, g, h) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (e); phospho-ACCser79, serine phosphorylated ACC and total ACC (f); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (g); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (h). Confocal microscopy was performed using IL-6 receptor (IL-6R)-specific antibody (green) and DAPI (blue), with 50x magnification (i). Co-localization of IL-6R (green) and AMPK (red) and IL-6R (green) and phospho-p70S6K (red) 60 minutes after i.c.v. saline or IL-6 infusion in the arcuate nuclei of rats, with 200x magnification (j). Data are the means+/-SEM. *p<0.05, vs. control group; **p<0.01, vs. control group; # p<0.05, vs. other groups.
###end p 12
###begin p 13
###xml 684 693 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">figure 1a</xref>
If the effect of IL-6 on food intake is mediated by AMPK inhibition, AICAR infusion at doses that do not change food intake, but still increase AMPK and ACC phosphorylation, could be sufficient to block the effects of IL-6. Thus, to determine whether the effects of IL-6 on food intake are AMPK-dependent, we first identified a dose of AICAR that did not alter food intake (0.5 mM) when administered at the onset of the dark cycle. We then evaluated the effect of i.c.v. pretreatment with this dose of AICAR, or its vehicle, on the anorectic response to i.c.v. IL-6 (200 ng) and we observed that the anorectic response to i.c.v. IL-6 was reversed by AICAR at the time points studied (figure 1a). These findings indicate that inactivation of neuronal AMPK is necessary for some of the effects of IL-6 on food intake.
###end p 13
###begin p 14
###xml 160 169 160 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1i</xref>
###xml 617 626 617 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">Figure 1j</xref>
###xml 302 306 <span type="species:ncbi:10116">rats</span>
###xml 463 467 <span type="species:ncbi:10116">rats</span>
Immunohistochemistry with anti-Interleukin-6 Receptor (IL-6R)-specific antibody showed that IL-6R is expressed in a majority of neurons in the arcuate nucleus (Figure 1i). Double-staining confocal microscopy showed the positive immunoreactivity of IL-6R and AMPK in the hypothalamic arcuate nucleus of rats 60 minutes after i.c.v. saline or IL-6 (200 ng) infusion. The immunoreactivity of IL-6R and pp70S6K was not detected in the hypothalamic arcuate nucleus of rats after i.c.v. saline infusion. However, we observed the positive double-staining of IL-6R and pp70S6K 60 minutes after i.c.v. IL-6 (200 ng) infusion (Figure 1j).
###end p 14
###begin title 15
IL-6 induction of hypothalamic mTOR does not require changes in PI(3)K signaling
###end title 15
###begin p 16
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2a</xref>
###xml 529 545 529 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figures 2b and c</xref>
###xml 623 653 623 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figures 2b and c, lower panels</xref>
###xml 356 360 <span type="species:ncbi:10116">rats</span>
If the effect of IL-6 on food intake is mediated by mTOR activation, Rapamycin infusion at doses that do not change food intake, but still decrease p70S6K and 4EBP1 phosphorylations could be sufficient to block the effects of IL-6. Thus to determine whether IL-6 modulates hypothalamic mTOR signaling, we injected IL-6 (200 ng) into the third ventricle of rats and evaluated food intake and mTOR signaling. IL-6 caused a significant reduction in food intake (Figure 2a) and induced hypothalamic p70S6K and 4EBP1 phosphorylation (Figures 2b and c). The p70S6K and 4EBP1 protein levels were not different between the groups (Figures 2b and c, lower panels). To determine whether the effects of IL-6 on food intake are mTOR-dependent, we first identified a dose of Rapamycin that did not alter food intake (25 microg) when administered at the onset of the dark cycle. We then evaluated the effect of i.c.v. pretreatment with this dose of Rapamycin or its vehicle, on the anorectic response to i.c.v. IL-6 and we observed that IL-6 reduction of food intake was reversed by Rapamycin.
###end p 16
###begin title 17
Effects of IL-6 on food intake and hypothalamic PI(3)K/mTOR and JAK/STAT activity.
###end title 17
###begin p 18
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 226 232 226 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 306 311 306 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 575 581 575 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser473</sup>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 984 985 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 992 995 990 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1013 1014 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1021 1024 1019 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 194 205 <span type="species:ncbi:10116">Wistar rats</span>
###xml 551 562 <span type="species:ncbi:10116">Wistar rats</span>
###xml 814 825 <span type="species:ncbi:10116">Wistar rats</span>
(a) Pretreatment with Rapamycin blocks IL-6-induced anorexia (n = 10-12 animals per group). (b, c) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (b); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (c). (d) Pretreatment with LY294002 had no effect on anorectic response to IL-6 (n = 10-12). (e) Representative western blot of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-Aktser473, serine phosphorylated Akt and total Akt. (f) Pretreatment with AG490 blocks IL-6-induced anorexia (n = 10-12 animals per group). (g, h) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-JAK2, tyrosine phosphorylated JAK2 and total JAK2 (g); phospho-STAT3, Tyrosine phosphorylated STAT3 and total STAT3 (h). Data are the means+/-SEM. **p<0.01, vs. control group; # p<0.05, vs. other groups.
###end p 18
###begin p 19
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2d</xref>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2e</xref>
###xml 521 543 521 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2e, lower panel</xref>
We next examined whether PI(3)K signaling is required for the IL-6-dependent reduction of food intake, by IL-6 administration in LY294002 pretreated (i.c.v.) animals. Pretreatment with LY294002 at a dose that did not alter food intake (1 nmol) had no effect on anorectic response to i.c.v. IL-6 (Figure 2d). Consistent with these data, we observed that a single IL-6 i.c.v. injection did not change Akt phosphorylation status in the hypothalamus (Figure 2e). The Akt protein levels were not different between the groups (Figure 2e, lower panel). These findings indicates that activation of neuronal mTOR is necessary for some of the effects of IL-6 on food intake and that these effects of IL-6 do not require any change in PI(3)K signaling.
###end p 19
###begin p 20
###xml 168 177 168 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2f</xref>
###xml 236 252 236 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figures 2g and h</xref>
###xml 328 358 328 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figures 2g and h, lower panels</xref>
###xml 772 781 772 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g002">Figure 2f</xref>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
We also injected IL-6 (200 ng) into the third ventricle of rats and evaluated food intake and JAK2/STAT3 signaling. IL-6 caused a significant reduction in food intake (Figure 2f) and induced hypothalamic JAK2 and STAT3 phosphorylation (Figures 2g and h). The JAK2 and STAT3 protein levels were not different between the groups (Figures 2g and h, lower panels). To determine whether the effects of IL-6 on food intake are also JAK2/STAT3-dependent, we first identified a dose of AG490 that did not alter food intake when administered at the onset of the dark cycle. We then evaluated the effect of i.c.v. pretreatment with this dose of AG490 or its vehicle, on the anorectic response to i.c.v. IL-6 and we observed that IL-6 reduction of food intake was reversed by AG490 (Figure 2f).
###end p 20
###begin title 21
Physiological parameters measured in basal conditions after exercise protocol
###end title 21
###begin p 22
###xml 99 101 97 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 127 128 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 183 185 177 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 210 211 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 278 280 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
The plasma glucose level was lower in the exercised group compared to the control group (3.6+/-0.8 vs 4.6+/-0.5 mmol/L; n = 5; p<0.05) and the insulin levels were also lower (88+/-12 vs 193+/-17 pmol/L, n = 5; p<0.05). Exercise did not, however, reduce plasma leptin (2.6+/-0.5 vs 2.3+/-0.7 ng/ml). Insulinemia and leptinemia were not altered by third ventricle microinjection of leptin (data not shown).
###end p 22
###begin title 23
Exercise partially reverses the effects of AMPK agonists and fasting on food intake through modulation of the AMPK-mTOR signaling pathway in the hypothalamus
###end title 23
###begin p 24
###xml 373 382 373 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figure 3a</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 569 578 569 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figure 3a</xref>
###xml 238 242 <span type="species:ncbi:10116">rats</span>
###xml 437 441 <span type="species:ncbi:10116">rats</span>
To test the role of a single session of exercise on AICAR-increased food intake, AICAR (2 mM) or its vehicle were administered (i.c.v.) to control and exercised animals. 12-hour total food intake was measured after exercise. In exercised rats, AICAR (2 mM) did not cause any acute change in food intake but, in the control group, AICAR (2 mM) increased food intake by 32% (Figure 3a), suggesting that AICAR is not effective in exercised rats. Comparing AICAR-treated groups (control vs. exercise), exercised animals showed a 33% reduction in 12-hour total food intake (Figure 3a).
###end p 24
###begin title 25
###xml 132 136 <span type="species:ncbi:10116">rats</span>
AICAR, 2-DG and fasting effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control and exercised rats.
###end title 25
###begin p 26
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 697 698 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 860 866 860 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 925 930 925 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 992 998 992 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 1068 1073 1068 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 1151 1152 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1162 1163 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1170 1173 1168 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1191 1192 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1202 1203 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1210 1213 1208 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
###xml 266 277 <span type="species:ncbi:10116">Wistar rats</span>
###xml 342 346 <span type="species:ncbi:10116">rats</span>
###xml 549 560 <span type="species:ncbi:10116">Wistar rats</span>
###xml 835 846 <span type="species:ncbi:10116">Wistar rats</span>
(a) AICAR (2 mM) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n = 12-15 animals per group). (b, c, d, e) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. (f) 2-DG (500 mg/Kg) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n = 12-15 animals per group). (g, h, i, j) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. (k) Exercise decreases food intake in the fasting state (48 h fasting). Animals were immediately exposed to food for a 12-hour period (n = 12-15 animals per group). (l, m, n, o) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK; phospho-ACCser79, serine phosphorylated ACC and total ACC; phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K; phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1. Data are the means+/-SEM. * p<0.05, ** p<0.01, vs. control group; # p<0.05, ## p<0.001 vs. AICAR- or 2-DG-stimulated control group.
###end p 26
###begin p 27
###xml 217 233 217 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3b and c</xref>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 698 714 698 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3d and e</xref>
###xml 808 834 804 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3b&#8211;e, lower panels</xref>
###xml 953 964 949 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figure 3f&#8211;j</xref>
###xml 128 132 <span type="species:ncbi:10116">rats</span>
###xml 515 519 <span type="species:ncbi:10116">rats</span>
Consistent with food intake, AICAR increased AMPK threonine and ACC serine phosphorylation levels in the hypothalami of control rats, whilst in exercised animals, AICAR did not change AMPK/ACC phosphorylation status (Figures 3b and c). Comparing AICAR treated groups (control vs. exercise), exercised animals showed reductions in AMPK threonine and ACC serine phosphorylation of 52% and 31%, respectively. AICAR reduced p70S6K and 4EBP1 threonine phosphorylation levels in the hypothalamus of control and exercised rats. However, comparing AICAR treated groups (control vs. exercise), exercised animals showed increases in p70S6K and 4EBP1 threonine phosphorylation of 230% and 310%, respectively (Figures 3d and e). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 3b-e, lower panels). Similar results were observed after intraperitoneal treatment with 2-DG, another pharmacological activator of AMPK (Figure 3f-j).
###end p 27
###begin p 28
###xml 398 407 386 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figure 3k</xref>
###xml 452 455 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 582 598 570 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3l and m</xref>
###xml 635 638 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 763 779 751 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3n and o</xref>
###xml 873 899 857 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g003">Figures 3l&#8211;o, lower panels</xref>
###xml 321 325 <span type="species:ncbi:10116">rats</span>
To be sure that the experiments represent a physiological condition we measured food intake in control and exercised animals after fasting. In the control animals, prolonged fasting (48 hours) increased approximately35% of food intake during 12-hours of refeeding period compared to control group. However, in the fasted rats, acute exercise session prevented fasting-induced hyperphagic response (Figure 3k). Comparing fasting treated groups (control vs. exercise), exercised animals showed reductions in AMPK threonine and ACC serine phosphorylation of 65% and 41%, respectively (Figures 3l and m). Comparing fasting groups (control vs. exercise), exercised animals showed increases in p70S6K and 4EBP1 threonine phosphorylation of 261% and 240%, respectively (Figures 3n and o). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 3l-o, lower panels).
###end p 28
###begin title 29
Intracerebroventricular alpha-LA reduces food intake by modulating AMPK-mTOR hypothalamic phosphorylation levels to a greater extent in exercised animals
###end title 29
###begin p 30
###xml 152 156 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Kim1">[34]</xref>
###xml 514 517 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 600 609 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g004">Figure 4a</xref>
###xml 371 375 <span type="species:ncbi:10116">rats</span>
alpha-LA is an essential cofactor of mitochondrial respiratory enzymes and exerts potent anti-obesity effects by suppressing hypothalamic AMPK activity [34]. The effects of alpha-LA (3 microg) intracerebroventricular administration, or its vehicle, on food intake control were studied by measuring the 12-hour total food intake after an acute exercise bout. In exercised rats, alpha-LA (3 microg) reduced food intake by 86% while control group showed a reduction of 58%. Comparing alpha-LA treated groups (control vs. exercise), exercised animals showed a 64% reduction in 12-hour total food intake (Figure 4a).
###end p 30
###begin title 31
###xml 117 121 <span type="species:ncbi:10116">rats</span>
alpha-LA effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control and exercised rats.
###end title 31
###begin p 32
###xml 135 136 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 297 303 289 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 366 371 358 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 437 443 429 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 517 522 509 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 604 605 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 612 615 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 633 634 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 641 644 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 66 70 <span type="species:ncbi:10116">rats</span>
###xml 272 283 <span type="species:ncbi:10116">Wistar rats</span>
(a) alpha-LA (3 microg) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n = 8-10 animals per group). (b, c, d, e) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACCser79, serine phosphorylated ACC and total ACC (c); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (e). Data are the means+/-SEM. * p<0.05, vs. control group; # p<0.05, vs. exercised non-stimulated group.
###end p 32
###begin p 33
###xml 355 358 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 505 521 489 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g004">Figures 4b and c</xref>
###xml 202 206 <span type="species:ncbi:10116">rats</span>
###xml 306 310 <span type="species:ncbi:10116">rats</span>
To determine the effects of exercise on the AMPK-mTOR signaling pathway, alpha-LA was i.c.v. administered and AMPK, ACC, p70S6K and 4EBP1 phosphorylation levels were assessed in the hypothalamus of all rats. alpha-LA reduced AMPK and ACC phosphorylation levels, in the hypothalami of control and exercised rats. Comparing alpha-LA treated groups (control vs. exercise), in exercised animals alpha-LA reduced both AMPK threonine phosphorylation and ACC serine phosphorylation of 39% and 57%, respectively (Figures 4b and c).
###end p 33
###begin p 34
###xml 153 156 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 282 298 270 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g004">Figures 4d and e</xref>
###xml 378 404 358 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g004">Figures 4b&#8211;e, lower panels</xref>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
alpha-LA induced p70S6K and 4EBP1 threonine phosphorylation in the hypothalami of control and exercised rats. Comparing alpha-LA treated groups (control vs. exercise), in exercised animals, alpha-LA increased p70S6K and 4EBP1 threonine phosphorylation of 19% and 11%, respectively (Figures 4d and e). alpha-LA did not change alphaAMPK, ACC, p70S6K and 4EBP1 protein expression (Figures 4b-e, lower panels).
###end p 34
###begin title 35
Intracerebroventricular leptin reduces food intake by modulating AMPK-mTOR hypothalamic phosphorylation levels to a greater extent in exercised animals
###end title 35
###begin p 36
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 517 526 517 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g005">Figure 5a</xref>
###xml 190 194 <span type="species:ncbi:10116">rats</span>
The effects of leptin (10-6 M) i.c.v. administration or its vehicle on food intake control were studied by measuring the 12-hour total food intake after an acute exercise bout. In exercised rats, leptin (10-6 M) reduced food intake by 43%, when compared with exercised plus vehicle treated group, while the control group showed a reduction of 25%, when compared with vehicle treated group. Comparing leptin-treated groups (control vs. exercise), exercised animals showed a 31% reduction in 12-hour total food intake (Figure 5a).
###end p 36
###begin title 37
###xml 115 119 <span type="species:ncbi:10116">rats</span>
Leptin effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control and exercised rats.
###end title 37
###begin p 38
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 294 300 294 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 363 368 363 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 434 440 434 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 514 519 514 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 601 602 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 612 613 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 620 623 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 641 642 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 652 653 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 659 662 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 62 66 <span type="species:ncbi:10116">rats</span>
###xml 269 280 <span type="species:ncbi:10116">Wistar rats</span>
(a) Leptin (10-6 M) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n = 12-15 animals per group). (b, c, d, e) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACCser79, serine phosphorylated ACC and total ACC (c); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (e). Data are the means+/-SEM. * p<0.05, ** p<0.01, vs. control group; # p<0.05, ## p<0.01 vs. leptin-stimulated control group.
###end p 38
###begin p 39
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 493 509 493 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g005">Figures 5b and c</xref>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 793 809 793 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g005">Figures 5d and e</xref>
###xml 903 929 899 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g005">Figures 5b&#8211;e, lower panels</xref>
###xml 196 200 <span type="species:ncbi:10116">rats</span>
###xml 297 301 <span type="species:ncbi:10116">rats</span>
###xml 615 619 <span type="species:ncbi:10116">rats</span>
To determine the effects of exercise on AMPK-mTOR signaling pathway, leptin was i.c.v. administered and AMPK, ACC, p70S6K and 4EBP1 phosphorylation levels were assessed in the hypothalamus of all rats. Leptin reduced AMPK and ACC phosphorylation levels in the hypothalami of control and exercised rats. Comparing leptin-treated groups (control vs. exercise), in exercised animals, leptin reduced both AMPK threonine phosphorylation and ACC serine phosphorylation of 57% and 45%, respectively (Figures 5b and c). Leptin induced p70S6K and 4EBP1 threonine phosphorylation in the hypothalamus of control and exercised rats. Comparing leptin treated groups (control vs. exercise), in exercised animals, leptin increased both p70S6K and 4EBP1 threonine phosphorylation of 30% and 40% respectively (Figures 5d and e). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 5b-e, lower panels).
###end p 39
###begin title 40
Role of IL-6 in anorectic response to leptin
###end title 40
###begin p 41
###xml 124 133 124 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g006">Figure 6a</xref>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 519 528 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g006">Figure 6b</xref>
###xml 275 279 <span type="species:ncbi:10116">rats</span>
###xml 359 363 <span type="species:ncbi:10116">rats</span>
Hypothalamic IL-6 expression was detected in control animals; however, a 420% increase was observed in the exercised group (Figure 6a). We tested whether the inhibitory effects of leptin on food intake depends on IL-6, by i.c.v. infusion of anti-IL-6 antibody into exercised rats. Treatment with leptin (10-6 M) markedly reduced 12-h food intake in exercised rats pretreated with vehicle, although pretreatment with anti-IL-6 antibody blocked exercise-induced leptin responsiveness in a concentration-dependent manner (Figure 6b).
###end p 41
###begin title 42
Blockade of leptin induced inhibition of food intake by anti-IL-6 antibody.
###end title 42
###begin p 43
###xml 52 79 52 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Research Design and Methods</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 562 568 562 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 631 636 631 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 702 708 702 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 782 787 782 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 868 869 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 891 892 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 925 926 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 933 936 931 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 17 21 <span type="species:ncbi:10116">rats</span>
###xml 128 132 <span type="species:ncbi:10116">rats</span>
###xml 238 242 <span type="species:ncbi:10116">rats</span>
###xml 254 258 <span type="species:ncbi:10116">rats</span>
###xml 273 277 <span type="species:ncbi:10116">rats</span>
###xml 537 548 <span type="species:ncbi:10116">Wistar rats</span>
Hypothalami from rats were prepared as described in Research Design and Methods. (a) Tissue extracts from control and exercised rats were immunoblotted with anti-IL-6 antibody. (b) Leptin was injected intracerebroventricularly in control rats, exercised rats and exercised rats pretreated with anti-IL-6 at the doses indicated, and the animals were immediately exposed to food for a 12-hour period (n = 10-12 animals per group). (c, d, e, f) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (c); phospho-ACCser79, serine phosphorylated ACC and total ACC (d); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (e); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (f). Data are the means+/-SEM. *p<0.05, vs. control, **p<0.05, vs. control plus leptin, #p<0.05, vs. exercise plus leptin.
###end p 43
###begin p 44
###xml 100 115 100 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g006">Figure 6c and d</xref>
###xml 255 271 255 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g006">Figures 6e and f</xref>
###xml 365 391 361 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g006">Figures 6c&#8211;f, lower panels</xref>
Both AMPK and ACC phosphorylation levels, reduced by exercise, were reversed by anti-IL-6 antibody (Figure 6c and d). We also observed that the increased phosphorylations of p70S6K and 4EBP1, induced by exercise, were also reversed by anti-IL-6 infusion (Figures 6e and f). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 6c-f, lower panels).
###end p 44
###begin title 45
###xml 92 96 <span type="species:ncbi:10116">rats</span>
The role of IL-6 on leptin responsiveness in the hypothalamus of diet-induced obesity (DIO) rats
###end title 45
###begin p 46
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figure 7a</xref>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 781 790 781 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figure 7b</xref>
###xml 115 119 <span type="species:ncbi:10116">rats</span>
###xml 234 238 <span type="species:ncbi:10116">rats</span>
###xml 289 293 <span type="species:ncbi:10116">rats</span>
###xml 498 502 <span type="species:ncbi:10116">rats</span>
###xml 529 533 <span type="species:ncbi:10116">rats</span>
###xml 593 597 <span type="species:ncbi:10116">rats</span>
###xml 717 721 <span type="species:ncbi:10116">rats</span>
###xml 767 771 <span type="species:ncbi:10116">rats</span>
###xml 924 928 <span type="species:ncbi:10116">rats</span>
We next investigated the effect of IL-6 on leptin responsiveness in the hypothalamus of diet-induced obesity (DIO) rats after acute exercise. Hypothalamic IL-6 expression was detected in the hypothalamus of diet-induced obesity (DIO) rats; however, a 156% increase was observed in the DIO rats after acute exercise (Figure 7a). The effects of leptin (10-6 M) i.c.v. administration on energy intake control were studied by measuring the 12-hour total food intake after an acute exercise bout in DIO rats. Comparing leptin-treated rats (control vs. DIO), the energy intake was 28% higher in DIO rats after leptin infusion. However, the i.c.v. infusion of leptin was able to reduce the energy intake by about 31% in DIO rats after the exercise protocol, compared to DIO rats at rest (Figure 7b). Interestingly, the i.c.v. pretreatment with anti-IL-6 antibody (25 ng) blunted the anorexigenic effects of leptin in exercised DIO rats.
###end p 46
###begin title 47
###xml 123 127 <span type="species:ncbi:10116">rats</span>
Leptin effects on 12-h cumulative food intake and AMPK/mTOR signaling in the hypothalami of control, DIO and exercised DIO rats.
###end title 47
###begin p 48
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 473 479 473 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 542 547 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 613 619 613 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 693 698 693 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 780 781 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 788 791 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 809 810 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 817 820 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 109 120 <span type="species:ncbi:10116">Wistar rats</span>
###xml 238 242 <span type="species:ncbi:10116">rats</span>
###xml 448 459 <span type="species:ncbi:10116">Wistar rats</span>
(a) Representative Western blots of five independent experiments showing hypothalamic IL-6 expression in DIO Wistar rats at rest and immediately after acute exercise. (b) Leptin (10-6 M) was administered in control, DIO and exercised DIO rats. Animals were immediately exposed to food for a 12-hour period (n = 12-15 animals per group). (c, d, e and f) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (c); phospho-ACCser79, serine phosphorylated ACC and total ACC (d); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (e); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (f). Data are the means+/-SEM. * p<0.05, vs. control group, # p<0.05, vs. DIO group.
###end p 48
###begin p 49
###xml 428 443 428 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figure 7c and d</xref>
###xml 751 767 751 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figures 7c and d</xref>
###xml 837 867 837 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figures 7c and d, lower panels</xref>
###xml 99 103 <span type="species:ncbi:10116">rats</span>
###xml 352 356 <span type="species:ncbi:10116">rats</span>
###xml 463 467 <span type="species:ncbi:10116">rats</span>
###xml 551 555 <span type="species:ncbi:10116">rats</span>
###xml 745 749 <span type="species:ncbi:10116">rats</span>
To determine the effects of exercise on the AMPK-mTOR signaling pathway in the hypothalamus of DIO rats, leptin was i.c.v. administered and AMPK, ACC, p70S6K and 4EBP1 phosphorylation levels were assessed in the hypothalamus. The suppressive effects of i.c.v. infusion of leptin on AMPK and ACC phosphorylation were impaired in the hypothalamus of DIO rats by about 58 and 54%, respectively, when compared to the control group (Figure 7c and d). In exercised DIO rats, leptin reduced the phosphorylation of AMPK by 65% and ACC by 37%, compared to DIO rats at rest and the i.c.v. pretreatment with anti-IL6 antibody before the exercise protocol, reversed the suppressive effects of leptin on AMPK/ACC pathway in the hypothalamus of exercised DIO rats (Figures 7c and d). The AMPK and ACC protein levels did not differ between the groups (Figures 7c and d, lower panels).
###end p 49
###begin p 50
###xml 456 472 456 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figures 7e and f</xref>
###xml 550 566 550 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g007">Figures 7e and f</xref>
###xml 73 77 <span type="species:ncbi:10116">rats</span>
###xml 305 309 <span type="species:ncbi:10116">rats</span>
###xml 450 454 <span type="species:ncbi:10116">rats</span>
In addition, p70S6K and 4EBP1 phosphorylation in the hypothalamus of DIO rats after i.c.v. leptin infusion was reduced by about 46% and 45%, respectively, when compared to the control group. In exercised DIO animals, leptin increased the phosphorylation of p70S6K by 62% and 4EBP1 by 59%, compared to DIO rats at rest. I.c.v. pretreatment with anti-IL6 antibody before the exercise protocol blocked these effects in the hypothalamus of exercised DIO rats (Figures 7e and f). The p70S6K and 4EBP1 protein levels were not different between the groups (Figures 7e and f, lower panels).
###end p 50
###begin title 51
Blocking effects of AICAR and Rapamycin on leptin-induced anorexia
###end title 51
###begin p 52
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 499 501 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 506 515 502 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g008">Figure 8a</xref>
###xml 557 559 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1009 1011 1005 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1117 1133 1113 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g008">Figures 8b and c</xref>
###xml 320 324 <span type="species:ncbi:10116">rats</span>
###xml 576 580 <span type="species:ncbi:10116">rats</span>
###xml 1018 1022 <span type="species:ncbi:10116">rats</span>
We tested whether the i.c.v. administration of AICAR or Rapamycin, 60 minutes before the administration of leptin (10-6 M), prevents the anorexigenic effects of leptin. Leptin (10-6 M) treatment markedly reduced 12-h food intake in both control and exercised groups, although leptin was much more effective in exercised rats. AICAR (0.5 mM) or Rapamycin (25 microg), at doses that do not alter ingestion, completely blocked the suppression of food intake induced by an i.c.v. injection of leptin (10-6 M) (Figure 8a). The i.c.v. administration of leptin (10-6 M) to exercised rats pretreated with vehicle reduced AMPK and ACC phosphorylation in the hypothalamus by 63% and 60% respectively, compared with the control group. The administration of AICAR increased AMPK threonine and ACC serine phosphorylation, although at this dose, AICAR was not sufficient to induce significant an increase in food intake in exercised animals (data not shown). Comparing exercised animals, i.c.v. administration of leptin (10-6 M) to rats pretreated with AICAR increased both AMPK and ACC phosphorylation levels in the hypothalamus (Figures 8b and c).
###end p 52
###begin title 53
Blocking effects of AICAR and Rapamycin on leptin-induced anorexia.
###end title 53
###begin p 54
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 265 271 265 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 334 339 334 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser79</sup>
###xml 405 411 405 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr389</sup>
###xml 485 490 485 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr70</sup>
###xml 571 572 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 579 582 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
###xml 240 251 <span type="species:ncbi:10116">Wistar rats</span>
(a) Effect of i.c.v. administration of leptin on exercised rats; pretreatment with AICAR or Rapamycin (n = 8-10 animals per group). (b, c, d, e) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPKthr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACCser79, serine phosphorylated ACC and total ACC (c); phospho-p70S6Kinasethr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (e). Data are the means+/-SEM. *p<0.05, vs. other groups.
###end p 54
###begin p 55
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 489 505 489 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g008">Figures 8d and e</xref>
###xml 599 625 595 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g008">Figures 8b&#8211;e, lower panels</xref>
###xml 58 62 <span type="species:ncbi:10116">rats</span>
###xml 284 288 <span type="species:ncbi:10116">rats</span>
The i.c.v. administration of leptin (10-6 M) to exercised rats pretreated with vehicle induced p70S6K and 4EBP1 phosphorylation in the hypothalamus of 60% and 70%, respectively, compared with the control group. Comparing exercised animals, i.c.v. administration of leptin (10-6 M) to rats pretreated with AICAR reduced both p70S6K and 4EBP1 phosphorylation levels in the hypothalamus. Exercised animals pretreated with Rapamycin also reduced hypothalamic p70S6K and 4EBP1 phosphorylation (Figures 8d and e). The alphaAMPK, ACC, p70S6K and 4EBP1 protein levels were not different between the groups (Figures 8b-e, lower panels).
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 152 155 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Shapiro1">[6]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Bi1">[35]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Bruce1">[36]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Martins2">[38]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Bruce1">[36]</xref>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Shapiro1">[6]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Santti1">[39]</xref>
###xml 169 175 <span type="species:ncbi:9606">humans</span>
###xml 744 748 <span type="species:ncbi:10116">rats</span>
###xml 879 883 <span type="species:ncbi:10116">rats</span>
###xml 1283 1287 <span type="species:ncbi:10116">rats</span>
During the last decade, a substantial number of studies have investigated the role of physical activity in the control of energy intake in rodents [5], [6], [35] and in humans [36]-[38]. However, the molecular mechanisms by which exercise controls food intake are still unsolved. Several experimental studies have demonstrated that neither acute [5], [36] nor chronic [6], [39] exercise per se change food intake, on the other hand, accumulating evidence shows that both acute and chronic exercise potentiate the anorexigenic effects of leptin in the hypothalamus. Our data indicate that IL-6 signaling through AMPK and mTOR reduces food intake in a dose-dependent manner. Leptin, as well as alpha-LA infusion, reduced food intake in exercised rats to a greater extent than that observed in control animals. Conversely, AICAR, 2-DG and fasting increased food intake in exercised rats to a lower extent than that observed in control animals. Exercise was associated with the effects of leptin on the AMPK/mTOR pathway activity in the hypothalamus. In addition, we investigated the regulatory role of IL-6 in mediating the increase in leptin responsiveness in the hypothalamus. Treatment with leptin markedly reduced food intake, AMPK activity and increased mTOR activity in exercised rats that were pretreated with vehicle, although no increase in response to leptin-induced anorexia and modulation of AMPK/mTOR pathway were detected after i.c.v. pretreatment with anti-IL-6 antibody. Taken together, these results suggest that IL-6 is a major component of the effects of exercise on the control of food intake.
###end p 57
###begin p 58
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Daval1">[40]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Minokoshi2">[42]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Minokoshi1">[12]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Andersson1">[43]</xref>
###xml 563 575 563 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003856-g001">figures 1b&#8211;d</xref>
###xml 459 463 <span type="species:ncbi:10116">rats</span>
Increasing evidence shows that leptin and IL-6 activates AMPK in the peripheral tissues, such as skeletal muscle and adipose tissue, increasing fatty acid oxidation and glucose uptake in these tissues [40]-[42], however, leptin has an opposing effect in hypothalamic tissue, reducing neuronal AMPK activity [12], [43]. As well as in response to leptin, in the present study, we demonstrated that IL-6 alone reduced AMPK phosphorylation in the hypothalamus of rats. We also show that, IL-6 increased ATP levels and decreased the AMP/ATP ratio in the hypothalamus (figures 1b-d), but the mechanisms by which IL-6 modulates the ATP levels require further investigations.
###end p 58
###begin p 59
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Minokoshi1">[12]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Kim1">[34]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Carling1">[44]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Hardie1">[45]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Gao1">[10]</xref>
###xml 1325 1331 1325 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thr172</sup>
###xml 1144 1148 <span type="species:ncbi:10116">rats</span>
A number of recent studies have shown that AMPK plays a key role in regulating both energy intake and expenditure [12], [34], [44], [45]. In peripheral tissues, such as skeletal muscle, activation of AMPK switches on energy producing pathways and switches off energy consuming pathways. In the hypothalamus, activation of AMPK leads to increased feeding, thereby increasing energy intake. Conversely, inhibition of AMPK in the hypothalamus reduces food intake. These dual functions of AMPK suggest that it may act to coordinate energy expenditure with energy intake. There is already some evidence that this may be the case in one situation. More recently, Gao and colleagues [10] demonstrated that the hypothalamic ACC activation makes an important contribution to the anorexigenic effects of leptin that are mediated by AMPK. The aim of this study was to investigate whether IL-6 could affect AMPK activity in the hypothalamus, thereby providing a potential mechanism for the coordination of energy expenditure and energy intake during, or following exercise. Beyond STAT3 activation, we detected changes in the hypothalamic AMPK activity in rats after i.c.v. infusion of IL-6; we show that, IL-6 markedly decreased phospho-AMPK abundance (an index of activity) in the hypothalamus. In accordance with the reduction in AMPKthr172 phosphorylation, we observed that, after IL-6 administration, hypothalamic AMP:ATP ratio was decreased.
###end p 59
###begin p 60
###xml 16 20 16 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wallenius1">[28]</xref>
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wallenius2">[46]</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10116">rats</span>
###xml 586 590 <span type="species:ncbi:10116">rats</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
Wallenius et al [28] elegantly showed that long-term peripheral IL-6 treatment to Il6-/- mice caused a decrease in body weight. In addition to increasing energy expenditure, IL-6 may prevent obesity by inhibiting feeding as obese IL-6-/- mice had increased absolute food intake. However, central IL-6 treatment at the same dose that we used does not influence food intake in mice. In concordance with our results another study of the same group showed a reduced daily food intake over a two-week ICV treatment period with IL-6 in rats indicating a different pattern of response between rats and mice [46].
###end p 60
###begin p 61
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Cota1">[13]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Ropelle1">[15]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Boulton1">[47]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-AlKhalili1">[48]</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Weigert3">[51]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Carey1">[52]</xref>
###xml 478 482 <span type="species:ncbi:10116">rats</span>
The mTOR, an evolutionary conserved serine-threonine kinase, central to integrating similar signals to control food intake, has now emerged as a detector of hormonal and nutritional signals in the hypothalamus [13], [15]. In this study, we investigated whether IL-6 activates mTOR. IL-6 increased mTOR activity; moreover inhibition of central mTOR reversed the anorectic effect of IL-6. In addition, the anorexigenic effect of IL-6 was absent in AICAR- and Rapamycin-pretreated rats, however, pretreatment with LY294002 - a PI(3)K inhibitor - had no effect on IL-6 induced anorexia, indicating that, in the hypothalamus, the effect of IL-6 is independent of the PI(3)K pathway. Signaling through gp130 commonly results in activation of PI(3)K, and IL-6 can activate PI(3)K [47] and its downstream target Akt [48]-[51], but it should be noted that this effect has not been observed in all studies [52], suggesting a tissue-dependent effect.
###end p 61
###begin p 62
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Andersson1">[43]</xref>
###xml 447 451 <span type="species:ncbi:10116">rats</span>
Next, we investigated whether the increased sensitivity of the leptin action on food intake induced by exercise, could be due to the modulation of AMPK activity. As previously shown [43], exercise, per se, does not alter AMPK activity in the hypothalamus; however, we observed that the normal inhibition of AMPK phosphorylation and activity in the hypothalamus, induced by leptin administration, was improved in both lean and diet-induced obesity rats after acute protocol of exercise.
###end p 62
###begin p 63
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Reznick1">[53]</xref>
###xml 114 118 <span type="species:ncbi:10116">rats</span>
###xml 292 296 <span type="species:ncbi:10116">rats</span>
###xml 386 390 <span type="species:ncbi:10116">rats</span>
In addition, we did not observe any normal stimulation of AMPK activity by AICAR in the hypothalamus of exercised rats, indicating that AMPK pathway is disrupted. This observation agrees with data from aging studies in which acute stimulation with AICAR was blunted in skeletal muscle of old rats [53]. Furthermore, fasting and the use of another activator of AMPK (2-DG) in exercising rats resulted in a lower activation of AMPK when compared to the control animals. In contrast, the pharmacological inhibition of AMPK by alpha-LA results in a greater inhibition of AMPK activity, compared to control animals.
###end p 63
###begin p 64
The mechanism by which exercise inhibits AMPK-induced food intake in the hypothalamus is not clear. Several lines of evidence point to a possible link between inhibited AMPK-induced food intake in the hypothalamus and IL-6 signaling through the AMPK/mTOR pathway. Firstly, we found that the leptin-inhibited food intake enhanced by exercise was blunted by anti-IL-6 antibody. Secondly, exercise induced increased response of leptin-inhibited AMPK signaling was reverted by AICAR. Finally, exercise induced increased responsiveness of leptin stimulated mTOR signaling was reverted by rapamycin.
###end p 64
###begin p 65
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wallenius1">[28]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Stouthard1">[54]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Tsigos1">[56]</xref>
###xml 263 266 263 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 268 271 268 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Shapiro1">[6]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Wallenius1">[28]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Rothwell1">[55]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Li1">[57]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Nybo1">[58]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Nybo1">[58]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Pedersen1">[21]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Febbraio1">[59]</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Pedersen2">[60]</xref>
###xml 130 136 <span type="species:ncbi:9606">humans</span>
###xml 168 172 <span type="species:ncbi:10116">rats</span>
Our data are in accordance with earlier studies demonstrating that IL-6 treatment enhances energy expenditure in both rodents and humans [28], [54]-[56]. In exercising rats, hypothalamic leptin and insulin responsiveness are increased in an IL-6-dependent manner [5], [6]. It has been previously shown that IL-6 treatment stimulates energy expenditure at the level of the brain in rodents [28], [55], [57], and it might be assumed that endogenous IL-6 also acts on the brain during exercise. The IL-6 exerting this effect during exercise could be produced by the brain itself, which has been shown to have increased IL-6 production during exercise [58]. Alternatively, the large quantities of endocrine IL-6 produced from working skeletal muscle [58] might reach appropriate sites in the brain [21], [59], [60].
###end p 65
###begin p 66
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Flores1">[5]</xref>
###xml 399 402 <span type="species:ncbi:10116">rat</span>
Interestingly, we did not observe any difference in food intake over a 12-h period, although the levels of hypothalamic IL-6 dramatically increased after exercise. At first glance, these data appear to be contradictory. However, a large decrease in insulin level was observed after exercise, and we have previously shown a synergic effect of IL-6 on the insulin and leptin signaling pathway, in the rat hypothalamus [5]. Since we did not observe modifications in the phosphorylation of JAK2 and the downstream targets of mTOR after exercise, these data suggest that the cross-talk between insulin, IL-6 and leptin have an essential role in controlling food intake after exercise. In this case, it is possible that increases in IL-6 levels were counterbalanced by the reduction in insulin levels.
###end p 66
###begin p 67
However, the present study has certain limitations. Exercise per se did not evoke any meaningful effect in terms of food intake; rather, it seemed to enhance the anorectic effect of exogenous leptin. Thus, the data presented herein may suggest but do not establish the mechanism by which long term exercise decreases leptin levels; whilst increases the response to leptin, contributing to its food-suppressive actions. Furthermore, settings of activation of AMPK or inactivation of mTOR were selected to induce changes in target protein phosphorylation, but not food intake. Such dissociation does not preclude a pharmacological rather than physiological effect of our data.
###end p 67
###begin p 68
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Martin1">[61]</xref>
###xml 587 591 <span type="species:ncbi:10116">rats</span>
Increased responsiveness of leptin action in the hypothalamus, through modulation of the AMPK-mediated pathway by exercise, could be pathophysiologically important in the prevention of obesity. Recent studies have shown that modulation of leptin signaling through the AMPK pathway could be involved in the development of obesity [61]. Taken together, these data indicate that the anti-obesity actions, induced by leptin, could be increased due to the more pronounced inhibition of the AMPK pathway observed after leptin infusion in the hypothalamus of both lean and diet-induced obesity rats after acute exercise. If the mechanism used by IL-6 to reduce food intake is AMPK-dependent, as our results suggest, the defective activation of AMPK in the hypothalamic neurons induced by exercise may increase the ability of leptin to reduce food intake.
###end p 68
###begin p 69
###xml 471 475 <span type="species:ncbi:10116">rats</span>
In conclusion, exercise improved the AMPK and mTOR responses to leptin administration and contributed to appetite-suppressive actions. This increased dynamic responsiveness of the AMPK/mTOR pathway to leptin could provide information regarding the molecular mechanism underlying the biological sensitivity to leptin in exercise. Furthermore, these findings provide support to the hypothesis that AMPK and mTOR interact in the hypothalamus to control feeding in exercised rats, in an IL-6-dependent manner.
###end p 69
###begin title 70
Methods
###end title 70
###begin title 71
Antibodies and Chemicals
###end title 71
###begin p 72
###xml 636 638 632 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 695 704 691 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1007/1008</sup>
###xml 1038 1041 1034 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">172</sup>
###xml 252 258 <span type="species:ncbi:9913">bovine</span>
###xml 645 651 <span type="species:ncbi:9986">rabbit</span>
###xml 712 718 <span type="species:ncbi:9986">rabbit</span>
###xml 820 824 <span type="species:ncbi:9925">goat</span>
###xml 859 865 <span type="species:ncbi:9986">rabbit</span>
###xml 899 905 <span type="species:ncbi:9986">rabbit</span>
###xml 941 947 <span type="species:ncbi:9986">rabbit</span>
###xml 1054 1060 <span type="species:ncbi:9986">rabbit</span>
###xml 1097 1103 <span type="species:ncbi:9986">rabbit</span>
###xml 1154 1160 <span type="species:ncbi:9986">rabbit</span>
###xml 1212 1218 <span type="species:ncbi:9986">rabbit</span>
###xml 1252 1258 <span type="species:ncbi:9986">rabbit</span>
###xml 1307 1313 <span type="species:ncbi:9986">rabbit</span>
###xml 1346 1352 <span type="species:ncbi:9986">rabbit</span>
###xml 1401 1407 <span type="species:ncbi:9986">rabbit</span>
###xml 1442 1448 <span type="species:ncbi:9986">rabbit</span>
Reagents for SDS-polyacrylamide gel electrophoresis and immunoblotting were from Bio-Rad (Richmond, CA, USA). Tris[hydroxymethyl]amino-methane (Tris), aprotinin, ATP, dithiothreitol, phenylmethylsulfonyl fluoride, Triton X-100, Tween 20, glycerol, and bovine serum albumin (fraction V) were from Sigma Aldrich (St. Louis, MO, USA). Protein A-Sepharose 6 MB and Nitrocellulose paper (Hybond ECL, 0.45 microm) from Amersham Pharmacia Biotech United Kingdom Ltd. (Buckinghamshire, United Kingdom). Ketamin was from Parke-Davis (Sao Paulo, SP, Brazil) and diazepam and thiopethal were from Cristalia (Itapira, SP, Brazil). Anti-phospho-[Ser79] ACC (rabbit polyclonal, #07-184) and anti-phospho- [Tyr1007/1008] JAK2 (rabbit polyclonal, AB3805) antibodies were from Upstate Biotechnology (Charlottesville, VA, USA). Anti-ACC (goat polyclonal, sc-26816), anti-JAK2 (rabbit polyclonal, sc 278), anti-STAT3 (rabbit polyclonal, sc 483) and anti-IL-6 (rabbit polyclonal, sc-7920) antibodies were from Santa Cruz Biotechnology, Inc. Anti-phospho-[Thr172] AMPKalpha (rabbit polyclonal, #2531), anti-AMPKalpha (rabbit polyclonal, #2532), anti-phospho- [tyr705] STAT3 (rabbit polyclonal, #9135), anti-phospho- [Thr389] p70S6K (rabbit polyclonal, #9205), anti-p70S6K (rabbit polyclonal, #9202), anti-phospho- [Thr70]4EBP1 (rabbit polyclonal, #9455), anti-4EBP1 (rabbit polyclonal, #9452), anti-phospho- [Ser 473]Akt (rabbit polyclonal, #9271), and anti-Akt (rabbit polyclonal, #9272) were from Cell Signalling Technology (Beverly, MA, USA). Leptin, LY294002, and Interleukin-6 were from Calbiochem (San Diego, CA, USA); 5-Aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR), 2-Deoxy-D-glucose and alpha-lipoic acid were from Sigma Chemical Co. (St. Louis, MO). Rapamycin was from LC Laboratories (Woburn, MA, USA). Routine reagents were purchased from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.
###end p 72
###begin title 73
Serum insulin and leptin quantification
###end title 73
###begin p 74
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 196 200 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Scott1">[62]</xref>
Plasma was separated by centrifugation (1100 g) for 15 minutes at 4degreesC and stored at -80degreesC until assayed. RIA was employed to measure serum insulin, according to a previous description [62]. Leptin concentrations were determined using a commercially available Enzyme Linked Immuno Sorbent Assay (ELISA) kit (Crystal Chem Inc, Chicago, IL).
###end p 74
###begin title 75
Experimental Animals
###end title 75
###begin p 76
###xml 296 344 296 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Guide for the Care and Use of Laboratory Animals</italic>
###xml 5 16 <span type="species:ncbi:10116">Wistar rats</span>
Male Wistar rats (8 weeks old/250-300 g) obtained from the University of Campinas Animal Breeding Center were used in the experiments. The investigation was approved by the ethics committee and followed the University guidelines for the use of animals in experimental studies and conforms to the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH publication no. 85-23 revised 1996). The animals were maintained on 12h:12h artificial light-dark cycles and housed in individual cages.
###end p 76
###begin title 77
Diet induced obesity (DIO)
###end title 77
###begin p 78
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 206 208 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 210 220 210 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Pauli1">[63]</xref>
###xml 14 25 <span type="species:ncbi:10116">Wistar rats</span>
Male 4-wk-old Wistar rats from the University of Campinas Breeding Center were randomly divided into two groups, control, fed standard rodent chow (3948 kcal.Kg-1) and DIO, fed a fat-rich chow (5358 kcal.Kg-1) ad libitum for 3 months and then submitted to the different experimental protocols. This diet composition has been previously used [63].
###end p 78
###begin title 79
Intracerebroventricular (i.c.v.) cannulation
###end title 79
###begin p 80
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Carvalheira1">[64]</xref>
The animals were stereotaxically instrumented under intraperitoneal injection of a mix of ketamin (10 mg) and diazepam (0.07 mg) (0.2 ml/100 g body weight) with a chronic 26-gauge stainless steel indwelling guide cannula, aseptically placed into the third ventricle (0.5 mm posterior and 8.5 mm ventral to bregma), as previously described [64]. After a 1-wk recovery period, cannula placement was confirmed by a positive drinking response after administration of Angiotensin II (40 ng/2 microL); animals that did not drink 5 mL of water within 15 minutes after treatment were not included in the experiment.
###end p 80
###begin title 81
Exercise Protocol
###end title 81
###begin p 82
###xml 344 348 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Ropelle2">[65]</xref>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 385 389 <span type="species:ncbi:10116">rats</span>
###xml 491 495 <span type="species:ncbi:10116">rats</span>
Rats were acclimated to swimming for 2 days (10 min per day). On the day of the experiment, animals swam in groups of four, in plastic barrels of 45 cm in diameter, filled to a depth of 50 cm. Water temperature was maintained at 34-35degreesC. They performed two 3-h exercise bouts, separated by one 45-min rest period, as previously described [65]. After the last exercise bout, some rats were injected into the cannula and food intake was determined over the next 4 and/or 12 h; the other rats were injected into the cannula and then anesthetized with intraperitoneal injection of sodium thiopethal (5 mg/100 g body weight) and hypothalamus was removed.
###end p 82
###begin title 83
Treatments
###end title 83
###begin p 84
###xml 339 341 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 22 26 <span type="species:ncbi:10116">rats</span>
###xml 426 430 <span type="species:ncbi:10116">rats</span>
For acute treatments, rats were deprived of food for 6 h with free access to water and i.p. injected (200 microl bolus injection) with either vehicle or 2-DG (500 mg/kg) or i.c.v. injected (3 microl bolus injection) with either vehicle, IL-6 (100 ng or 200 ng), AICAR (0.5 or 2.0 mM), Rapamycin (25 microg), alpha-LA (3 microg), leptin (10-6 M), LY294002 (50 microM) or anti-IL-6 antibody. Similar studies were carried out in rats that were initially pre-treated with i.c.v. microinjection of vehicle, AICAR, Rapamycin, anti-IL-6 antibody or LY294002, and after 60 min with i.c.v. microinjection of IL-6 or leptin. Thereafter, standard chow was given and food intake was determined by measuring the difference between the weight of chow given and the weight of chow at the end of 4 and/or 12-h periods. All acute treatments were performed at 5:00 and 6:00 p.m.
###end p 84
###begin title 85
Western Blot Analysis
###end title 85
###begin p 86
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Carvalheira2">[66]</xref>
###xml 1329 1330 1319 1320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1332 1333 1322 1323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1344 1345 1334 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1348 1349 1338 1339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1855 1872 1839 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scion Corporation</italic>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 262 266 <span type="species:ncbi:10116">rats</span>
After exercise and i.c.v. treatments, rats were anaesthetized with intraperitoneal injection of a mix of ketamin (10 mg) and diazepam (0.07 mg) (0.2 ml/100 g body weight), and used as soon as anesthesia was assured by the loss of pedal and corneal reflexes. The rats were killed, and hypothalamus was quickly removed, minced coarsely and homogenized immediately in a freshly prepared ice-cold buffer (1% Triton X-100, 100 mmol/l Tris pH 7.4, 100 mmol/l sodium pyrophosphate, 100 mmol/l sodium fluoride, 10 mmol/l EDTA, 10 mmol/l sodium vanadate, 2 mmol/l phenyl methylsulphonyl fluoride and 0.1 mg aprotinin) suitable for preserving phosphorylation states of enzymes and Western blot was performed, as previously described [66]. Insoluble material was removed by centrifugation (50 000 g) for 25 minutes at 4degreesC. Total extracts of hypothalamus were prepared and 0.25 mg total proteins were separed by SDS-PAGE. After SDS-PAGE (15% resolving gels for phospho-4EBP1 and 4EBP1; 12% resolving gels for phospho-AMPK, AMPKalpha2; phospho-p70S6K, p70S6K, phospho-Akt, Akt, phospho-STAT3 and STAT3; 8% resolving gels for phosphor-JAK2 and JAK2; 6.5% resolving gels for ACC and phospho-ACC), proteins were transferred from gel to nitrocellulose membrane. Membranes were blocked in 5% nonfat dried milk in PBST (139 mM NaCl, 2.7 mM KH2PO4, 9.9 mM Na2HPO4, and 0.1% Tween 20) for 2 hours and then incubated overnight with specific antibodies. After incubation with the relative second antibody, immune complexes were detected using the ECL method. Results were visualized by autoradiography using preflashed Kodak XAR film (Eastman Kodak, Rochester, N.Y., USA) with Cronex Lightning Plus intensifying screens at -80degreesC for 12-48 h. (Mass., USA). Band intensities were quantified by optical densitometry of developed autoradiographs (Scion Image software - Scion Corporation, Frederick, Md., USA).
###end p 86
###begin title 87
Confocal microscopy
###end title 87
###begin p 88
###xml 420 424 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Araujo1">[67]</xref>
###xml 644 648 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003856-Mai1">[68]</xref>
###xml 114 118 <span type="species:ncbi:10116">rats</span>
Paraformaldehyde-fixed hypothalami were sectioned (5 microm). The sections were obtained from hypothalamus of six rats per group in the same localization (antero-posterior = -1.78 from bregma) and used in regular single- or double-immunofluorescence staining using DAPI, anti-IL6 receptor (IL6R), anti-AMPK, anti-phospho-p70S6K (1:200; Santa Cruz Biotechnology), antibodies, according to a previously described protocol [67]. Analysis and photodocumentation of results were performed using a LSM 510 laser confocal microscope (Zeiss, Jena, Germany). The anatomical correlations were made according to the landmarks given in a stereotaxic atlas [68].
###end p 88
###begin title 89
Chromatography
###end title 89
###begin p 90
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 52 56 <span type="species:ncbi:10116">rats</span>
After exercise, i.c.v. infusion of IL-6 or vehicle, rats were anaesthetized, and used as soon as anesthesia was assured by the loss of pedal and corneal reflexes. The animals were killed and, within 40 seconds, the cranium was opened, the brain was removed and the hypothalamus was quickly dissected and frozen in liquid N2 for chromatographic analyses.
###end p 90
###begin p 91
###xml 681 682 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 684 685 680 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1625 1626 1609 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1636 1637 1620 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 1646 1647 1630 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1653 1654 1637 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1663 1664 1647 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1685 1686 1669 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1730 1731 1714 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
Chromatographic analyses were carried out on a Waters Alliance equipment series 2695 (Milford, MA, USA) equipped with a quaternary pump, an autosampler, a degasser, and a Waters 2475 fluorescence detector model. The fluorescence of derivatized compounds (ATP, ADP, AMP, and ADO) was monitored with excitation and emission wavelengths set at 280 and 420 nm, respectively. Chromatographic separations of the compounds were achieved at room temperature, using a reversed-phase Cosmosil 5C18-MS column (150x4.6 mm i.d.; 5 microm particle size) with a Cosmosil guard column (5C18-MS 10x4.6 mm) purchased from Phenomenex (Torrance, CA, USA). The mobile phase composition was 50 mmol/L KH2PO4, 25 mmol/L citric acid (pH 4.5), and methanol (90:10, v/v), which was prepared immediately before use and filtered through a 0.45 microm filter (Millipore, Milford, MA, USA). The column was equilibrated and eluted under isocratic conditions using a flow rate of 1.0 ml/min. The chromatographic run time for each analysis was 20 min. Aliquots of 25 microl were injected into the HPLC system. System control, data acquisition, and processing were performed with a PC-Pentium IV Processor personal computer from Dell, operated with Microsoft Windows XP version 2003 and Waters Empower 2002 chromatography software. A validation chromatographic run included a set of calibration samples assayed in duplicate and quality control samples at four levels in triplicate. The standard calibration curves for known amounts of ATP, ranging from 0.025 to 10.0 micromol/L, were linear (R>0.999) and could be described by the linear regression equation: y = 0.4992*x-0.0463 (n = 4, P<0.0001, r = 0.9997), in which y is the ATP concentration in micromoles and x is the chromatogram peak area.
###end p 91
###begin title 92
Statistical Analysis
###end title 92
###begin p 93
###xml 309 329 307 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bonferroni post test</italic>
###xml 367 368 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All numeric results are expressed as the means+/-SEM of the indicated number of experiments. The results of blots are presented as direct comparisons of bands or spots in autoradiographs and quantified by optical densitometry (Scion Image). Statistical analysis was performed by employing the ANOVA test with Bonferroni post test. Significance was established at the p<0.05 level.
###end p 93
###begin p 94
We thank Dr Nicola Conran for English language editing.
###end p 94
###begin title 95
References
###end title 95
###begin article-title 96
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Effects of exercise-rest cycles on energy balance in rats.
###end article-title 96
###begin article-title 97
The role of exercise in thermogenesis and energy balance.
###end article-title 97
###begin article-title 98
Involvement of corticotropin-releasing factor in the anorexia induced by exercise.
###end article-title 98
###begin article-title 99
Successful weight loss maintenance.
###end article-title 99
###begin article-title 100
###xml 68 79 <span type="species:ncbi:10116">Wistar rats</span>
Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats.
###end article-title 100
###begin article-title 101
###xml 152 156 <span type="species:ncbi:10116">rats</span>
Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats.
###end article-title 101
###begin article-title 102
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
###end article-title 102
###begin article-title 103
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Diet-induced obese mice develop peripheral, but not central, resistance to leptin.
###end article-title 103
###begin article-title 104
Central nervous system control of food intake.
###end article-title 104
###begin article-title 105
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake.
###end article-title 105
###begin article-title 106
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
###end article-title 106
###begin article-title 107
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.
###end article-title 107
###begin article-title 108
Hypothalamic mTOR signaling regulates food intake.
###end article-title 108
###begin article-title 109
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin.
###end article-title 109
###begin article-title 110
A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss.
###end article-title 110
###begin article-title 111
Integration of growth factor and nutrient signaling: implications for cancer biology.
###end article-title 111
###begin article-title 112
Mammalian TOR: a homeostatic ATP sensor.
###end article-title 112
###begin article-title 113
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
###end article-title 113
###begin article-title 114
A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
###end article-title 114
###begin article-title 115
The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.
###end article-title 115
###begin article-title 116
Searching for the exercise factor: is IL-6 a candidate?
###end article-title 116
###begin article-title 117
###xml 50 55 <span type="species:ncbi:9606">human</span>
Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise.
###end article-title 117
###begin article-title 118
###xml 43 48 <span type="species:ncbi:9606">human</span>
Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.
###end article-title 118
###begin article-title 119
###xml 24 29 <span type="species:ncbi:9606">human</span>
IL-6 gene expression in human adipose tissue in response to exercise-effect of carbohydrate ingestion.
###end article-title 119
###begin article-title 120
###xml 38 43 <span type="species:ncbi:9606">human</span>
Metabolic effects of interleukin-6 in human splanchnic and adipose tissue.
###end article-title 120
###begin article-title 121
Interleukin-6 Regulation of AMP-Activated Protein Kinase: Potential Role in the Systemic Response to Exercise and Prevention of the Metabolic Syndrome.
###end article-title 121
###begin article-title 122
###xml 56 60 <span type="species:ncbi:10090">mice</span>
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise.
###end article-title 122
###begin article-title 123
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Interleukin-6-deficient mice develop mature-onset obesity.
###end article-title 123
###begin article-title 124
Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.
###end article-title 124
###begin article-title 125
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.
###end article-title 125
###begin article-title 126
Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.
###end article-title 126
###begin article-title 127
A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.
###end article-title 127
###begin article-title 128
Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways.
###end article-title 128
###begin article-title 129
C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
###end article-title 129
###begin article-title 130
###xml 93 97 <span type="species:ncbi:10116">rats</span>
Running wheel activity prevents hyperphagia and obesity in Otsuka long-evans Tokushima Fatty rats: role of hypothalamic signaling.
###end article-title 130
###begin article-title 131
###xml 94 98 <span type="species:ncbi:10116">rats</span>
Postexercise muscle triacylglycerol and glycogen metabolism in obese insulin-resistant zucker rats.
###end article-title 131
###begin article-title 132
Effects of exercise and restrained eating behaviour on appetite control.
###end article-title 132
###begin article-title 133
Short-term appetite control in response to a 6-week exercise programme in sedentary volunteers.
###end article-title 133
###begin article-title 134
###xml 111 115 <span type="species:ncbi:10116">rats</span>
Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
###end article-title 134
###begin article-title 135
Functions of AMP-activated protein kinase in adipose tissue.
###end article-title 135
###begin article-title 136
AMP-activated protein kinase signaling in metabolic regulation.
###end article-title 136
###begin article-title 137
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.
###end article-title 137
###begin article-title 138
###xml 12 16 <span type="species:ncbi:10116">rats</span>
Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity.
###end article-title 138
###begin article-title 139
The AMP-activated protein kinase cascade-a unifying system for energy control.
###end article-title 139
###begin article-title 140
Management of cellular energy by the AMP-activated protein kinase system.
###end article-title 140
###begin article-title 141
###xml 70 74 <span type="species:ncbi:10116">rats</span>
Intracerebroventricular interleukin-6 treatment decreases body fat in rats.
###end article-title 141
###begin article-title 142
Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors.
###end article-title 142
###begin article-title 143
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
###end article-title 143
###begin article-title 144
###xml 87 92 <span type="species:ncbi:9606">human</span>
Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
###end article-title 144
###begin article-title 145
###xml 66 71 <span type="species:ncbi:9606">human</span>
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt.
###end article-title 145
###begin article-title 146
Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells.
###end article-title 146
###begin article-title 147
###xml 63 69 <span type="species:ncbi:9606">humans</span>
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
###end article-title 147
###begin article-title 148
Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis.
###end article-title 148
###begin article-title 149
###xml 57 63 <span type="species:ncbi:9606">humans</span>
Endocrinologic and metabolic effects of interleukin-6 in humans.
###end article-title 149
###begin article-title 150
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Interleukin-6 is a centrally acting endogenous pyrogen in the rat.
###end article-title 150
###begin article-title 151
###xml 28 33 <span type="species:ncbi:9606">human</span>
Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.
###end article-title 151
###begin article-title 152
###xml 193 197 <span type="species:ncbi:10116">rats</span>
Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats.
###end article-title 152
###begin article-title 153
###xml 31 36 <span type="species:ncbi:9606">human</span>
Interleukin-6 release from the human brain during prolonged exercise.
###end article-title 153
###begin article-title 154
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles.
###end article-title 154
###begin article-title 155
Exercise and the immune system: regulation, integration, and adaptation.
###end article-title 155
###begin article-title 156
Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle.
###end article-title 156
###begin article-title 157
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans.
###end article-title 157
###begin article-title 158
###xml 148 159 <span type="species:ncbi:10116">Wistar rats</span>
Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats.
###end article-title 158
###begin article-title 159
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Insulin modulates leptin-induced STAT3 activation in rat hypothalamus.
###end article-title 159
###begin article-title 160
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation.
###end article-title 160
###begin article-title 161
###xml 79 83 <span type="species:ncbi:10116">rats</span>
Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats.
###end article-title 161
###begin article-title 162
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Blockade of IRS1 in isolated rat pancreatic islets improves glucose-induced insulin secretion.
###end article-title 162
###begin p 163
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 163
###begin p 164
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: These studies were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento cientifico e tecnologico (CNPq).
###end p 164

